Almac has expanded its drug product pharmaceutical development services with a new non-GMP formulation development facility and two new analytical labs at its headquarters in Craigavon, doubling current capacity.   Although dedicated to non-GMP development, the facilities will employ all of the company’s technical capabilities of its existing GMP pharmaceutical development facility, including high levels of control over environmental conditions, as well as extending current capabilities in proce...